Immunic IMUX Cash Flow Statement (2013-2026)

NASDAQ IMUX
$7.48 +0.07 (+0.94%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Immunic Quarterly Cash Flow Statement

Periods 54 quarters
Latest Jun 2026

Immunic reported cash from operations of -$31.00M and free cash flow of -$31.25M for the quarter ended Jun 2026, down 26.0% year over year. This cash flow statement covers 54 quarters of results from Mar 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-19.29M-21.19M-20.81M-21.90M-21.22M-56.47M-25.27M-24.00M-22.77M-21.57M-29.58M-21.38M-24.37M-25.18M-25.47M-26.82M-25.58M-19.30M-32.59M-34.10M
Depreciation and DepletionDep. & Depletion
0.02M0.03M0.02M0.02M0.03M0.02M0.03M0.03M0.03M0.04M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.02M0.04M0.02M0.02M0.02M0.02M0.03M0.02M0.03M0.02M0.03M0.03M0.04M0.04M0.04M0.04M0.04M0.04M0.03M0.03M
Share-based CompensationStock Comp.
1.40M4.14M2.07M2.06M1.91M1.89M1.98M1.80M1.69M1.64M2.75M1.88M1.91M1.99M2.04M1.90M3.61M1.31M4.47M6.78M
Gains from Sales and DivestituresGains Divest
Asset Writedowns and ImpairmentWritedown
33.00M
Other non-cash itemsOther Non-Cash
1.30M1.13M0.15M1.95M2.11M0.54M0.52M0.15M0.05M-0.19M0.34M-0.49M0.06M0.12M
Change in Working Capital
Change in Account PayablesChange Payables
-0.74M0.44M-0.35M1.18M0.33M-0.35M0.99M-0.54M-1.40M1.77M1.79M1.18M-2.11M2.27M-2.08M1.19M-0.03M2.16M1.09M1.77M
Change in Accured ExpensesChange Accured Exp.
-3.40M0.51M0.56M-1.42M0.76M-0.02M2.07M2.39M1.50M4.32M-6.15M1.73M2.52M-2.96M4.71M-1.26M1.43M-0.40M4.21M-4.53M
Change in Other Operating AssetsOther Assets Change
-2.38M6.50M2.27M-2.41M-1.92M-5.43M-0.12M-0.19M-3.57M0.02M-0.39M0.01M-1.09M-0.43M0.84M-0.41M-0.38M3.12M-5.21M0.72M
Change in Other Operating LiabilitiesOther Liabilities Change
0.75M0.42M-0.05M-0.06M0.58M0.90M0.05M0.01M0.02M0.01M-0.20M-0.14M0.05M0.45M-0.23M-0.12M-0.04M-0.32M0.12M-0.44M
Other Working Capital ChangesOther WC Changes
3.13M-6.08M-2.32M2.35M2.50M6.33M0.17M0.20M3.59M-0.01M0.19M-0.16M1.14M0.88M-1.07M0.29M0.34M-3.44M5.34M-1.17M
Other Operating ActivitiesOther Ops.
Cash from OperationsCash from Ops.
-17.60M-23.68M-20.68M-15.76M-13.60M-15.10M-19.51M-19.98M-17.31M-14.03M-23.97M-17.04M-20.80M-22.96M-21.78M-24.61M-20.14M-19.28M-17.30M-31.00M
Investing Activities
Capital ExpendituresCapex
0.02M0.02M0.01M0.03M0.07M0.00M0.10M0.02M0.04M0.17M0.03M0.18M0.05M0.00M0.05M0.04M0.07M0.01M0.00M0.25M
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in Property, Plant and EquipmentChange in PP&E
-0.02M-0.02M-0.01M-0.03M-0.07M0.00M-0.10M-0.02M-0.04M-0.17M-0.03M-0.18M-0.05M0.00M-0.05M-0.04M-0.07M-0.01M0.00M-0.25M
Purchase of InvestmentsInvestments Purchased
Sale and Maturity of InvestmentsInvestments Sold
5.44M4.36M
Change in Acquisitions & DivestmentsChange Acquisitions
5.44M4.36M
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
-0.02M-0.02M-0.01M-0.03M-0.07M-9.63M5.34M4.34M-0.04M-0.17M-0.03M-0.18M-0.05M0.00M-0.05M-0.04M-0.07M-0.01M0.00M-0.25M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
74.27M65.40M
Non-Current Debt
74.27M65.40M
Net Debt Issuances and RepaymentsNet Debt Issuance
74.27M65.40M
Change in Capital Stock
Common Stock IssuedStock Issued
0.09M29.64M10.08M-39.53M0.05M0.10M0.28M0.60M0.19M0.08M0.12M0.06M187.26M0.12M
Net Shares Issued and RepurchasedNet Shares Issued
0.09M29.64M10.08M-39.53M0.05M0.10M0.28M0.60M0.19M0.08M0.12M0.06M187.26M0.12M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.09M29.64M10.08M-39.53M0.05M0.10M0.28M0.60M0.19M0.08M0.12M0.06M187.26M0.12M
Other financing activitiesOther financing
Cash from Financing ActivitiesCash from Financing
42.02M0.82M29.64M10.08M56.04M0.05M0.10M0.28M0.60M74.46M0.08M65.52M0.06M188.64M0.12M
Additional items
Exchange Rate EffectFX Effect
-1.13M-0.70M-0.10M-1.92M-1.64M2.67M0.14M0.08M-0.53M0.57M0.17M-0.40M0.22M-0.51M0.46M0.13M0.03M-0.42M-0.19M-0.40M
Change in Cash
23.27M-23.58M8.85M-7.63M-15.31M33.97M-13.98M-15.47M-17.61M-13.02M50.64M-17.61M-20.63M-23.40M-21.36M41.01M-20.18M-19.65M171.15M-31.53M
Ending Cash Balance
110.44M86.86M95.71M88.08M72.77M106.75M92.76M77.29M59.69M46.67M97.31M79.70M59.07M35.67M14.30M55.31M35.13M15.48M186.63M155.10M
Free Cash FlowFCF
-17.62M-23.70M-20.69M-15.79M-13.67M-15.10M-19.62M-20.00M-17.36M-14.19M-24.00M-17.22M-20.85M-22.97M-21.82M-24.65M-20.21M-19.29M-17.30M-31.25M
Net Cash FlowNCF
24.40M-22.88M8.95M-5.72M-13.67M31.31M-14.13M-15.54M-17.07M-13.59M50.46M-17.22M-20.85M-22.89M-21.82M40.87M-20.21M-19.23M171.34M-31.13M
Interest Paid

Immunic Cash Flow Statement API

Pull Immunic's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IMUX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY